Biology Reference
In-Depth Information
John, G.K., et al., 2012. Primaquine radical cure of Plasmodium vivax : a critical review of the
literature. Malar. J. 11 (1), 280.
Kaneko, A., et al., 2000. Malaria eradication on islands. Lancet 356 (9241), 1560-1564.
Kaneko, A., 2010. A community-directed strategy for sustainable malaria elimination on
islands: short-term MDA integrated with ITNs and robust surveillance. Acta Trop. 114
(3), 177-183.
Karunajeewa, H.A., et al., 2008. A trial of combination antimalarial therapies in children
from Papua New Guinea. N. Engl. J. Med. 359, 2545-2557.
Karyana, M., et al., 2008. Epidemiology of multidrug resistant P. vivax and P. falciparum infec-
tion in Southern Papua, Indonesia. Malar. J. 7, 148.
Kinzer, M.H., et al., 2010. Active case detection, treatment of falciparum malaria with com-
bined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloro-
quine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
Malar. J. 9 (1), 89.
Kochar, D.K., et al., 2005. Plasmodium vivax malaria. Emerg. Infect. Dis. 11 (1), 132-134.
Kochar, D.K., et al., 2009. Severe Plasmodium vivax malaria: a report on serial cases from
Bikaner in Northwestern India. Am. J. Trop. Med. Hyg. 80 (2), 194-198.
Krishna, S., White, N.J., 1996. Pharmacokinetics of quinine, chloroquine and amodiaquine:
clinical implications. Clin. Pharmacokinet. 30 (4), 263-299.
Krudsood, S., et al., 2006. Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for
treatment of Plasmodium vivax malaria in Thailand. Korean J. Parasitol. 44 (3), 221-228.
Krudsood, S., et al., 2007. Clinical efficacy of chloroquine versus artemether-lumefantrine
for Plasmodium vivax treatment in Thailand. Korean J. Parasitol. 45 (2), 111-114.
Krudsood, S., et al., 2008. High-dose primaquine regimens against relapse of Plasmodium
vivax malaria. Am. J. Trop. Med. Hyg. 78 (5), 736-740.
LaMontagne, M.P., Blumbergs, P., Strube, R.E., 1982. Antimalarials. 14. 5-(aryloxy)-4-
methylprimaquine analogues. A highly effective series of blood and tissue schizonticidal
agents. J. Med. Chem. 25 (9), 1094-1097.
Lampah, D.A., et al., 2011. Coma associated with microscopy-diagnosed Plasmodium vivax : a
prospective study in Papua, Indonesia. PLoS Negl. Trop. Dis. 5 (6), e1032.
Lefevre, G., et al., 2001. A clinical and pharmacokinetic trial of six doses of artemether-
lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Am. J.
Trop. Med. Hyg. 64 (5-6), 247-256.
Leslie, T., et al., 2004. Compliance with 14-day primaquine therapy for radical cure of vivax
malaria: a randomized placebo-controlled trial comparing unsupervised with supervised
treatment. Trans. R. Soc. Trop. Med. Hyg. 98, 168-173.
Leslie, T., et al., 2008. A randomised trial of an eight-week, once weekly primaquine regimen
to prevent relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan. PLoS
One 3 (8), e2861.
Looareesuwan, S., et al., 1987. High rate of Plasmodium vivax relapse following treatment of
falciparum malaria in Thailand. Lancet 2 (8567), 1052-1055.
Lu, F., et al., 2011. In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax
from Central China. Am. J. Trop. Med. Hyg. 85 (2), 197-201.
Lux, D., et al., 2003. In-vitro sensitivity testing of Plasmodium vivax : response to lumefantrine
and chloroquine in Northwestern Thailand. Wien. Klin. Wochenschr. 115 (Suppl. 3),
50-54.
Luxemburger, C., et al., 1996. The epidemiology of malaria in a Karen population on the
western border of Thailand. Trans. R. Soc. Trop. Med. Hyg. 90 (2), 105-111.
Lwin, K.M., et al., 2012. Randomized, double-blind, placebo-controlled trial of monthly
versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high
risk of malaria. Antimicrob. Agents Chemother. 56 (3), 1571-1577.
Search WWH ::




Custom Search